| Serum progesterone concentration on day of HCG administration and IVF outcome. | |
| | |
MedLine Citation:
|
PMID: 18492365 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To determine the relationship between serum progesterone on the day of human chorionic gonadotrophin (HCG) and the pregnancy outcome of IVF-embryo transfer treatment, 251 infertile patients undergoing IVF-embryo transfer with gonadotrophin-releasing hormone agonist (GnRHa) and recombinant FSH (rFSH) were prospectively studied. Among them, 118 patients underwent 118 cycles of frozen embryo transfer (FET) treatment, one cycle per patient. All the cycles were grouped according to serum progesterone concentration on the day of HCG administration (<3.97 nmol/l or >/=3.97 nmol/l). The incidence of progesterone elevation was 36.7% (92/251), and in this group the pregnancy rate was significantly lower (25.97 versus 48.57%; P < 0.001). If the serum progesterone on the day of HCG was over 6.0 nmol/l, their pregnancy outcome was much poorer (13.79 versus 44.68%). However, the pregnancy rate was similar in FET cycles whether the serum progesterone was over 3.97 nmol/l (34.00 versus 36.76%) or 6.0 nmol/l (42.86 versus 34.02%). In conclusion, serum progesterone on the day of HCG may predict IVF pregnancy outcome. The higher serum oestradiol and progesterone concentrations may affect endometrial receptivity. For patients with an extremely high progesterone concentration on the day of HCG (such as over 6.0 nmol/l), transfer of frozen embryos in a natural cycle is suggested. |
| | |
Authors:
|
R Li; J Qiao; L Wang; X Zhen; Y Lu |
Related Documents
:
|
18096295 - Assessment of the predictive value of serum progesterone levels on early pregnancy prog... 9414445 - Inflammatory mediators and parturition. 21346695 - Managing cancer during pregnancy: what evidence do we have? 21294395 - The change of umbilical cord components in intrauterine growth restriction comparative ... 8733495 - Acute asthma during pregnancy. 10079495 - First-trimester cord entanglement in monoamniotic twins. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Reproductive biomedicine online Volume: 16 ISSN: 1472-6491 ISO Abbreviation: Reprod. Biomed. Online Publication Date: 2008 May |
Date Detail:
|
Created Date: 2008-05-21 Completed Date: 2008-08-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101122473 Medline TA: Reprod Biomed Online Country: England |
Other Details:
|
Languages: eng Pagination: 627-31 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Reproductive Medical Centre, Peking University Third Hospital, No. 49 Huayuan Bei Road, Haidian District, Beijing, 100083, People's Republic of China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chorionic Gonadotropin
/
administration & dosage* Estradiol / blood Female Fertilization in Vitro* Humans Pregnancy Pregnancy Outcome* Progesterone / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Chorionic Gonadotropin; 50-28-2/Estradiol; 57-83-0/Progesterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: What can we expect if we measure hormones in eumenorrhoeic infertile patients?
Next Document: Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for...